Search Results - "Andolina, Jeffrey R"

Reexamining 1-Gene Deletion α-Thalassemia: Is the Silent Carrier of Clinical Significance? by Andolina, Jeffrey R

Get more information

Early clinical observations on the use of imatinib mesylate in FOP: A report of seven cases by Kaplan, Frederick S., Andolina, Jeffrey R., Adamson, Peter C., Teachey, David T., Finklestein, Jerry Z., Ebb, David H., Whitehead, Benjamin, Jacobs, Benjamin, Siegel, David M., Keen, Richard, Hsiao, Edward, Pignolo, Robert J.

“…Fibrodysplasia ossificans progressiva (FOP) is an ultrarare genetic disorder of progressive, disabling heterotopic ossification (HO) for which there is…”
Get full text

Adjuvant immune checkpoint inhibitor therapy may benefit pediatric patients with stage III melanoma and sentinel lymph node positivity: a case series by Bowden, Acacia, Zambito, Jeanette, El-Feghaly, Jinia, Andolina, Jeffrey R

“…Melanoma is the most common skin cancer in children. While the current literature establishes treatment protocols for adult-type melanoma, very few…”
Get full text

Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies by Allen, Carl E., Marsh, Rebecca, Dawson, Peter, Bollard, Catherine M., Shenoy, Shalini, Roehrs, Philip, Hanna, Rabi, Burroughs, Lauri, Kean, Leslie, Talano, Julie-An, Schultz, Kirk R., Pai, Sung-Yun, Baker, K. Scott, Andolina, Jeffrey R., Stenger, Elizabeth O., Connelly, James, Ramirez, Alyssa, Bryant, Christopher, Eapen, Mary, Pulsipher, Michael A.

“…Allogeneic hematopoietic cell transplantation (HCT) with myeloablative conditioning for disorders associated with excessive inflammation such as hemophagocytic…”
Get full text

How I treat childhood CML by Andolina, Jeffrey R., Neudorf, Steven M., Corey, Seth J.

“…Chronic myeloid leukemia (CML) is composed of 3% of pediatric leukemias, making evidence-based recommendations difficult. Imatinib has revolutionized the…”
Get full text

Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group by Athale, Uma, Hijiya, Nobuko, Patterson, Briana C., Bergsagel, John, Andolina, Jeffrey R., Bittencourt, Henrique, Schultz, Kirk R., Burke, Michael J., Redell, Michele S., Kolb, E. Anders, Johnston, Donna L.

“…Chronic myeloid leukemia (CML) accounts for 2‐3% of leukemias in children under 15 and 9% in adolescents aged 15‐19. The diagnosis and management of CML in…”
Get full text

Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium by Thakar, Monica S, Logan, Brent R, Puck, Jennifer M, Dunn, Elizabeth A, Buckley, Rebecca H, Cowan, Morton J, O'Reilly, Richard J, Kapoor, Neena, Satter, Lisa Forbes, Pai, Sung-Yun, Heimall, Jennifer, Chandra, Sharat, Ebens, Christen L, Chellapandian, Deepak, Williams, Olatundun, Burroughs, Lauri M, Saldana, Blachy Davila, Rayes, Ahmad, Madden, Lisa M, Chandrakasan, Shanmuganathan, Bednarski, Jeffrey J, DeSantes, Kenneth B, Cuvelier, Geoffrey D E, Teira, Pierre, Gillio, Alfred P, Eissa, Hesham, Knutsen, Alan P, Goldman, Frederick D, Aquino, Victor M, Shereck, Evan B, Moore, Theodore B, Caywood, Emi H, Lugt, Mark T Vander, Rozmus, Jacob, Broglie, Larisa, Yu, Lolie C, Shah, Ami J, Andolina, Jeffrey R, Liu, Xuerong, Parrott, Roberta E, Dara, Jasmeen, Prockop, Susan, Martinez, Caridad A, Kapadia, Malika, Jyonouchi, Soma C, Sullivan, Kathleen E, Bleesing, Jack J, Chaudhury, Sonali, Petrovic, Aleksandra, Keller, Michael D, Quigg, Troy C, Parikh, Suhag, Shenoy, Shalini, Seroogy, Christine, Rubin, Tamar, Decaluwe, Hélène, Routes, John M, Torgerson, Troy R, Leiding, Jennifer W, Pulsipher, Michael A, Kohn, Donald B, Griffith, Linda M, Haddad, Elie, Dvorak, Christopher C, Notarangelo, Luigi D

“…Severe combined immunodeficiency (SCID) is fatal unless durable adaptive immunity is established, most commonly through allogeneic haematopoietic cell…”
Get full text

Multi‐institution analysis of tumor mutational burden and outcomes in pediatric central nervous system tumor patients by Parisi, Rose, Patel, Roshal R., Rood, Gavrielle, Bowden, Acacia, Turco, George, Korones, David N., Andolina, Jeffrey R., Comito, Melanie, Barth, Matthew, Weintraub, Lauren

“…Background Pediatric central nervous system (CNS) tumors are the leading cause of pediatric cancer mortality. Research addressing genomic biomarkers and…”
Get full text

Allogeneic hematopoetic stem cell transplantation in pediatric myelodysplastic syndromes: Improved outcomes for de novo disease by Andolina, Jeffrey R., Kletzel, Morris, Tse, William T., Jacobsohn, David A., Duerst, Reggie E., Schneiderman, Jennifer, Helenowski, Irene, Rademaker, Alfred, Chaudhury, Sonali

“…Andolina JR, Kletzel M, Tse WT, Jacobsohn DA, Duerst RE, Schneiderman J, Helenowski I, Rademaker A, Chaudhury S. Allogeneic hematopoetic stem cell…”
Get full text

Increased early mortality after fludarabine and melphalan conditioning with peripheral blood grafts in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide by Eastburg, Luke, Russler-Germain, David A., DiPersio, John F., Fountaine, Thomas, Andolina, Jeffrey R., Abboud, Ramzi, Huselton, Eric

“…Due to the evolving use of haploidentical donor grafts in hematopoietic cell transplantation, there is increased need to better understand the risks and…”
Get full text

Successful Bone Marrow Transplantation With Intensive Post-transplant Intrathecal Chemotherapy for CNS Relapsed AML in 2 Infants by Andolina, Jeffrey R., Fries, Carol, Boulware, Renee, Vargas, Alyssa, Fraint, Ellen, Barth, Matthew, Ambrusko, Steven, Comito, Melanie, Monteleone, Philip

“…Infant acute myeloid leukemia is a rare but aggressive form of leukemia. We report 2 children who presented with hyperleukocytosis, subsequently diagnosed with…”
Get full text

Off-on-off-on use of imatinib in three children with fibrodysplasia ossificans progressiva by Kaplan, Frederick S., Teachey, David T., Andolina, Jeffrey R., Siegel, David M., Mancilla, Edna E., Hsiao, Edward C., Al Mukaddam, Mona, Rocke, David M., Pignolo, Robert J.

“…The compassionate use of available medications with unproven efficacy is often in conflict with their clinical evaluation in placebo-controlled clinical…”
Get full text

Myeloablative Carboplatin and Thiotepa With Autologous Stem Cell Rescue for Nonmedulloblastoma High-risk CNS Tumors in Young Children by Fries, Carol, Girvin, Angela R., Korones, David N., Weintraub, Lauren, Fitzpatrick, Lorna, Andolina, Jeffrey R.

“…Malignant central nervous system (CNS) tumors in young children have a poor prognosis and pose a therapeutic challenge. We describe 11 patients with high-risk…”
Get full text

Migratory Arthralgia in a 3-year-old Girl by Fries, Carol, Long, Andrew M, Marston, Bethany A, Andolina, Jeffrey R

Get full text

Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children’s Oncology Group experience by Andolina, Jeffrey R., Wang, Yi-Cheng, Ji, Lingyun, Freyer, David R., Levine, John E., Pulsipher, Michael A., Gamis, Alan S., Aplenc, Richard, Roth, Michael E., Harrison, Lauren, Cairo, Mitchell S.

“…Adolescent and young adult (AYA) patients with acute leukemia (AL) have inferior outcomes in comparison to younger patients, and are more likely to develop…”
Get full text

Allogeneic Bone Marrow Transplant as a Cure for Refractory T-Cell Large Granular Lymphocytic Leukemia in an Adolescent by Fries, Carol, Evans, Andrew G., Cheon, HeeJin, Korones, David N., Loughran, Thomas P., Andolina, Jeffrey R.

“…T-cell large granular lymphocytic (T-LGL) leukemia is a rare, typically indolent neoplasm with a median age of onset above 60 years. Pathogenesis involves…”
Get full text

Gene Expression and Survival of Acute Lymphoblastic Leukemia Cells After Allogeneic Transplant by SCHENONE, DOMINIC, ANDOLINA, JEFFREY R., RADEMACHER, BROOKS, FOUNTAINE, THOMAS J., EDWARDS, ELENA, NUNEZ, LETI, QIU, MICHELLE, SHARMA, SONAKSHI, MULLEN, CRAIG A.

“…Background/Aim: This study explored the mechanisms of the allogeneic graft versus leukemia effect in acute lymphoblastic leukemia (ALL) cells by examining…”
Get full text

BCR/ABL1 Kinase Domain Mutation Monitoring: Could Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Benefit As Well? by Andolina, Jeffrey R

Get more information

Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML by Smith, Stephanie M., Zhang, Shiqi, Sundaram, Vandana, Roth, Michael, Andolina, Jeffrey R., Schapira, Lidia, Sakamoto, Kathleen M., Kolb, E. Anders, Hijiya, Nobuko, Chaudhury, Sonali

“…Chronic myeloid leukemia (CML) is effectively treated with long-term tyrosine kinase inhibitor (TKI) therapy, yet little is known about risks of prolonged TKI…”
Get full text

Factors Associated With Noncompliance With Long-term Follow-up Care Among Pediatric Cancer Survivors by Devine, Katie A, Viola, Adrienne, Capucilli, Peter, Sahler, Olle Jane Z, Andolina, Jeffrey R

“…Most childhood cancer survivors do not receive risk-based care through a survivorship program, but factors associated with dropping out of care are unclear…”
Get full text